Madde Kullanım Bozukluğuna Giriş
References
Volkow ND, Blanco C. Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry. 2023; 22(2): 203-229. doi: 10.1002/wps.21073
Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1223-49. doi: 10.1016/S0140-6736(20)30752-2
Eggert J, Theobald H, Engfeldt P. Effects of alcohol consumption on female fertility during an 18-year period. Fertil Steril. 2004;81(2): 379-383. doi: 10.1016/j.fertnstert.2003.06.018
Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005; 41(10): 1517-1524. doi:10.1086/497270
Martin CE, Scialli A, Terplan M. Unmet substance use disorder treatment need among reproductive age women. Drug and Alcohol Dependence. 2020; 206: 107679. doi: 10.1016/j.drugalcdep.2019.107679
Substance Abuse and Mental Health Services Administration (SAMHSA). Addressing the Needs of Women and Girls: Core Competencies for Mental Health and Substance Abuse Service Professionals. Published October 1, 2011. Accessed January 3, 2018.
Campbell AN, Barbosa‐Leiker C, Hatch‐Maillette M, et al. Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. The American journal on addictions. 2018;27(6):465-470. doi: 10.1111/ajad.12784
McHugh RK, Votaw VR, Sugarman DE, et al. Sex and gender differences in substance use disorders. Clinical psychology review. 2018; 66:12-23. doi: 10.1016/j.cpr.2017.10.012
Yalnız Dilcen H, Bilişli Y, Erdoğan A. Experiences of Women with Substance Use Disorder Regarding the Pregnancy Process. World Women Studıes Journal. 2022;7(1): 89–98. doi: 10.5281/zenodo.7460095
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
World Health Organization. International classification of diseases, 11th revision. Geneva: World Health Organization, 2021.
Olfson M, Crystal S, Wall MM, et al. Causes of death after nonfatal opioid overdose. JAMA Psychiatry. 2018;75:820-827. doi: 10.1001/jamapsychiatry.2018.1471
Blanco C, Wall MM, Hoertel N, et al. Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study. Mol Psychiatry. 2021;26:907-16. doi: 10.1038/s41380-019-0459-4
Deak JD, Johnson EC. Genetics of substance use disorders: a review. Psychological medicine. 2021;51(13):2189-2200. doi: 10.1017/S0033291721000969
Nieh EH, Kim SY, Namburi P, et al. Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors. Brain research. 2013; 1511: 73-92. doi: 10.1016/j.brainres.2012.11.001
Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci. 2017;18:741-752. doi: 10.1038/nrn.2017.130
Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol Rev. 2019;99:2115-2140. doi:10.1152/physrev.00014.2018
Gupta S, Kulhara P. Cellular and molecular mechanisms of drug dependence: an overview and update. Indian J Psychiatry. 2007;49:85-90. doi: 10.4103/0019-5545.33253
Volkow ND, Li TK. Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews Neuroscience. 2004; 5(12): 963-970.
Peciña S, Berridge KC. Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered “wanting” for reward: entire core and medial shell mapped as substrates for PIT enhancement. Eur J Neurosci. 2013;37:1529-1540. doi: 10.1111/ejn.12174
Langdon AJ, Sharpe MJ, Schoenbaum G, et al. Model-based predictions for dopamine. Curr Opin Neurobiol. 2018;49:1-7. doi: 10.1016/j.conb.2017.10.006
Dalley JW, Laane K, Theobald DEH, et al. Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci USA. 2005;102:6189-94. doi: 10.1073/pnas.0502080102
Sanchis-Segura C, Becker JB. Why we should consider sex (and study sex differences) in addiction research. Addict Biol. 2016;21(5):995–1006. doi: 10.1111/adb.12382.
AACAP. Practice parameters for the assesment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:609-621.
Ries RK, Fiellin DA, Miller SC. Et al. The ASAM principles of addiction medicine. Lippincott Williams & Wilkins; 2014.
Bozkurt M, Umut G, Evren C ve ark. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları, Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi. 2014; 27:328-334. doi: 10.5350/DAJPN2014270407
Yalnız Dilcen H, Genc R. The effects of Psychoeducation on the Traumatic Perception of the Birth Phenomenon in women with Substance-use Disorders. Substance Use & Misuse. 2019;54(12):2066-2074.doi: 10.1080/10826084.2019.1618335
Bukstein OG, Horner MS. Management of the adolescent with substance use disorders and comorbid psychopathology. Child and Adolescent Psychiatric Clinics. 2010;19(3):609-623. doi: 10.1016/j.chc.2010.03.011
Erdoğan A, Yalnız Dilcen H, Cinemre B. et al. Sociodemographic and clinical characteristics of patients admitted to an addiction center. Journal of Substance Use. 2022;27(3):321-327. doi: 10.1080/14659891.2021.1941352
Gilchrist G, Blázquez A, Torrens M. Exploring the relationship between intimate partner violence, childhood abuse and psychiatric disorders among female drug users in Barcelona. Adv Dual Diagn. 2012;5(2):46–58. doi:10.1108/17570971211241895.
Yalnız Dilcen H, Karaca Saydam B. Madde Bağımlılığı ve Prekonsepsiyonel Bakım, Danışmanlık, Demirel G, & Sayıner FD. (Eds.). Prekonsepsiyonel Bakım ve Danışmanlık. Ankara: Akademisyen Kitabevi. 2021;157-172.
Spooner C, Saktiawati MA, Lazuardi E, et al. Impacts of stigma on HIV risk for women who inject drugs in Java: a qualitative study. Int J Drug Pol. 2015; 26:1244–50. doi: 10.1016/j.drugpo.2015.07.011
Gilchrist G, Fonseca F, Torrens M. Access to treatment for people with alcohol and other substance abuse problems. Adicciones. 2011; 14;23(4):343-348.
Volkow N. Comment: It's time for addiction science to supersede stigma. Science news; 2008;174(10):40-40. doi: 10.1002/scin.2008.5591741027
Terplan M, Kennedy-Hendricks A, Chislom MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse Res Treat. 2015;9:1–4. doi: 10.4137/SART.S23328
Verissimo ADO, Grella CE. Influence of gender and race/ethnicity on perceived barriers to help seeking for alcohol or drug problems. J Subst Abus Treat. 2017;75:54–61. doi: 10.1016/j.jsat.2016.12.013.
Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21. doi:10.1016/j.drugalcdep.2006.05.012.
Fonseca F, Robles-Martínez M, Tirado-Muñoz J, et al. A gender perspective of addictive disorders. Current addiction reports. 2021;8: 89-99. doi: 10.1007/s40429-021-00357-9
Nebioğlu M, Yalnız H, Güven FM ve ark. Opiyat Bağımlılarında Diğer Maddelerin Kullanımı ve Sosyodemografik Özellikler ile İlişkisi. TAF Preventive Medicine Bulletin. 2013;12(1):35-42. doi: 10.5455/pmb.1353349703
Yalnız Dilcen H, Bılışlı Y. Erdoğan A. Experiences of Women with Substance Use Disorder Regarding the Pregnancy Process. World Women Studıes Journal. 2022;7(1): 89–98. doi: 10.5281/zenodo.7460095
Yalnız H, Nebioğlu M, Karacan BS ve ark. Madde bağımlılığı tanısı alan gençlerde cinsel yolla bulaşan hastalıklar ve aile planlaması ile ilgili bilgi düzeyi ve verilen eğitimin etkisi. Dusunen Adam: Journal of Psychiatry & Neurological Sciences. 2011; 24(2):106-112. doi: 10.5350/DAJPN20l1240203
Murray CJL, Aravkin AY, Zheng P, et al. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396:1223-49. doi: 10.1016/S0140-6736(20)30752-2
Eggert J, Theobald H, Engfeldt P. Effects of alcohol consumption on female fertility during an 18-year period. Fertil Steril. 2004;81(2): 379-383. doi: 10.1016/j.fertnstert.2003.06.018
Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005; 41(10): 1517-1524. doi:10.1086/497270
Martin CE, Scialli A, Terplan M. Unmet substance use disorder treatment need among reproductive age women. Drug and Alcohol Dependence. 2020; 206: 107679. doi: 10.1016/j.drugalcdep.2019.107679
Substance Abuse and Mental Health Services Administration (SAMHSA). Addressing the Needs of Women and Girls: Core Competencies for Mental Health and Substance Abuse Service Professionals. Published October 1, 2011. Accessed January 3, 2018.
Campbell AN, Barbosa‐Leiker C, Hatch‐Maillette M, et al. Gender differences in demographic and clinical characteristics of patients with opioid use disorder entering a comparative effectiveness medication trial. The American journal on addictions. 2018;27(6):465-470. doi: 10.1111/ajad.12784
McHugh RK, Votaw VR, Sugarman DE, et al. Sex and gender differences in substance use disorders. Clinical psychology review. 2018; 66:12-23. doi: 10.1016/j.cpr.2017.10.012
Yalnız Dilcen H, Bilişli Y, Erdoğan A. Experiences of Women with Substance Use Disorder Regarding the Pregnancy Process. World Women Studıes Journal. 2022;7(1): 89–98. doi: 10.5281/zenodo.7460095
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Arlington: American Psychiatric Association, 2013.
World Health Organization. International classification of diseases, 11th revision. Geneva: World Health Organization, 2021.
Olfson M, Crystal S, Wall MM, et al. Causes of death after nonfatal opioid overdose. JAMA Psychiatry. 2018;75:820-827. doi: 10.1001/jamapsychiatry.2018.1471
Blanco C, Wall MM, Hoertel N, et al. Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study. Mol Psychiatry. 2021;26:907-16. doi: 10.1038/s41380-019-0459-4
Deak JD, Johnson EC. Genetics of substance use disorders: a review. Psychological medicine. 2021;51(13):2189-2200. doi: 10.1017/S0033291721000969
Nieh EH, Kim SY, Namburi P, et al. Optogenetic dissection of neural circuits underlying emotional valence and motivated behaviors. Brain research. 2013; 1511: 73-92. doi: 10.1016/j.brainres.2012.11.001
Volkow ND, Wise RA, Baler R. The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci. 2017;18:741-752. doi: 10.1038/nrn.2017.130
Volkow ND, Michaelides M, Baler R. The neuroscience of drug reward and addiction. Physiol Rev. 2019;99:2115-2140. doi:10.1152/physrev.00014.2018
Gupta S, Kulhara P. Cellular and molecular mechanisms of drug dependence: an overview and update. Indian J Psychiatry. 2007;49:85-90. doi: 10.4103/0019-5545.33253
Volkow ND, Li TK. Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews Neuroscience. 2004; 5(12): 963-970.
Peciña S, Berridge KC. Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered “wanting” for reward: entire core and medial shell mapped as substrates for PIT enhancement. Eur J Neurosci. 2013;37:1529-1540. doi: 10.1111/ejn.12174
Langdon AJ, Sharpe MJ, Schoenbaum G, et al. Model-based predictions for dopamine. Curr Opin Neurobiol. 2018;49:1-7. doi: 10.1016/j.conb.2017.10.006
Dalley JW, Laane K, Theobald DEH, et al. Time-limited modulation of appetitive Pavlovian memory by D1 and NMDA receptors in the nucleus accumbens. Proc Natl Acad Sci USA. 2005;102:6189-94. doi: 10.1073/pnas.0502080102
Sanchis-Segura C, Becker JB. Why we should consider sex (and study sex differences) in addiction research. Addict Biol. 2016;21(5):995–1006. doi: 10.1111/adb.12382.
AACAP. Practice parameters for the assesment and treatment of children and adolescents with substance use disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:609-621.
Ries RK, Fiellin DA, Miller SC. Et al. The ASAM principles of addiction medicine. Lippincott Williams & Wilkins; 2014.
Bozkurt M, Umut G, Evren C ve ark. Sentetik kannabinoid kullanımı nedeniyle polikliniğe başvuran hastaların klinik özellikleri ve laboratuvar sonuçları, Düşünen Adam: Psikiyatri ve Nörolojik Bilimler Dergisi. 2014; 27:328-334. doi: 10.5350/DAJPN2014270407
Yalnız Dilcen H, Genc R. The effects of Psychoeducation on the Traumatic Perception of the Birth Phenomenon in women with Substance-use Disorders. Substance Use & Misuse. 2019;54(12):2066-2074.doi: 10.1080/10826084.2019.1618335
Bukstein OG, Horner MS. Management of the adolescent with substance use disorders and comorbid psychopathology. Child and Adolescent Psychiatric Clinics. 2010;19(3):609-623. doi: 10.1016/j.chc.2010.03.011
Erdoğan A, Yalnız Dilcen H, Cinemre B. et al. Sociodemographic and clinical characteristics of patients admitted to an addiction center. Journal of Substance Use. 2022;27(3):321-327. doi: 10.1080/14659891.2021.1941352
Gilchrist G, Blázquez A, Torrens M. Exploring the relationship between intimate partner violence, childhood abuse and psychiatric disorders among female drug users in Barcelona. Adv Dual Diagn. 2012;5(2):46–58. doi:10.1108/17570971211241895.
Yalnız Dilcen H, Karaca Saydam B. Madde Bağımlılığı ve Prekonsepsiyonel Bakım, Danışmanlık, Demirel G, & Sayıner FD. (Eds.). Prekonsepsiyonel Bakım ve Danışmanlık. Ankara: Akademisyen Kitabevi. 2021;157-172.
Spooner C, Saktiawati MA, Lazuardi E, et al. Impacts of stigma on HIV risk for women who inject drugs in Java: a qualitative study. Int J Drug Pol. 2015; 26:1244–50. doi: 10.1016/j.drugpo.2015.07.011
Gilchrist G, Fonseca F, Torrens M. Access to treatment for people with alcohol and other substance abuse problems. Adicciones. 2011; 14;23(4):343-348.
Volkow N. Comment: It's time for addiction science to supersede stigma. Science news; 2008;174(10):40-40. doi: 10.1002/scin.2008.5591741027
Terplan M, Kennedy-Hendricks A, Chislom MS. Prenatal substance use: exploring assumptions of maternal unfitness. Subst Abuse Res Treat. 2015;9:1–4. doi: 10.4137/SART.S23328
Verissimo ADO, Grella CE. Influence of gender and race/ethnicity on perceived barriers to help seeking for alcohol or drug problems. J Subst Abus Treat. 2017;75:54–61. doi: 10.1016/j.jsat.2016.12.013.
Greenfield SF, Brooks AJ, Gordon SM, et al. Substance abuse treatment entry, retention, and outcome in women: a review of the literature. Drug Alcohol Depend. 2007;86(1):1–21. doi:10.1016/j.drugalcdep.2006.05.012.
Fonseca F, Robles-Martínez M, Tirado-Muñoz J, et al. A gender perspective of addictive disorders. Current addiction reports. 2021;8: 89-99. doi: 10.1007/s40429-021-00357-9
Nebioğlu M, Yalnız H, Güven FM ve ark. Opiyat Bağımlılarında Diğer Maddelerin Kullanımı ve Sosyodemografik Özellikler ile İlişkisi. TAF Preventive Medicine Bulletin. 2013;12(1):35-42. doi: 10.5455/pmb.1353349703
Yalnız Dilcen H, Bılışlı Y. Erdoğan A. Experiences of Women with Substance Use Disorder Regarding the Pregnancy Process. World Women Studıes Journal. 2022;7(1): 89–98. doi: 10.5281/zenodo.7460095
Yalnız H, Nebioğlu M, Karacan BS ve ark. Madde bağımlılığı tanısı alan gençlerde cinsel yolla bulaşan hastalıklar ve aile planlaması ile ilgili bilgi düzeyi ve verilen eğitimin etkisi. Dusunen Adam: Journal of Psychiatry & Neurological Sciences. 2011; 24(2):106-112. doi: 10.5350/DAJPN20l1240203
Pages
1-14
Published
January 22, 2025
Copyright (c) 2025 Academician Publishing Book Portal
